Inc.;H. Lee Moffitt Cancer Center and Research Institute
发明人:
List, Alan F.,Wei, Sheng
申请号：
AU2020227092
公开号：
AU2020227092A1
申请日:
2020.09.04
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2020227092A120200924.pdf#####ABSTRACT Disclosed are compositions and methods for treating disease or condition caused or exacerbated by S100A9 activity, such as myelodysplastic syndromes (MDS) using a composition comprising an effective amount of a CD33/S100A9 inhibitor.
